ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Chernobyl Doctor’s Notes From Fukushima

April 1, 2011

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993

Pittsburgh, Norris Win Bristol-Myers Unrestricted Grants

April 19, 1991